London
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.
In a Nature Reviews Chemistry article, Prof. Angela Casini (TUM) and co-authors highlight the development and potential of a new generation of supramolecular radiopharmaceuticals for the therapy and diagnostics (theranostics) of cancer.
On the 14th November Marike Drexler (@TUM), our “SMARTdrugs” PhD student, had a stand at the study fair of König-Karlmann-Gymnasium Altötting.
On Friday 8th November 2024, Prof. Angela Casini (TUM) gave a lecture on medicinal inorganic chemistry, attended by PhDs and post docs as well as PIs of the Laboratoire de Chimie de Coordination (LCC) of the CNRS.
The first Annual Plenary Meeting of the SMARTdrugs network met at the TUM Science & Study Center Raitenhaslach on the 3rd – 4th of October. 2024.
It’s predicted from Cancer Research UK’s data that 1 in 2 of us will develop cancer in our lifetime. In this short documentary, and in collaboration with King’s College London, Understanding Animal Research explores one of the alternative models being used in cancer research. Professor Tim Witney explains how his team is trying to reduce the number of mice used in science and medical research when imaging cancer, by using chicken eggs.